YCT529 is an experimental non-hormonal male contraceptive developed by YourChoice Therapeutics. It functions as a selective antagonist of the retinoic acid receptor alpha, a nuclear receptor involved in vitamin A signaling. From Wikipedia
Larger trials will assess the pill’s contraceptive efficacy alongside determination of its optimal dosing in healthy men.